Ottawa, On June 27 2016
VMS Rehab Systems Inc (www.vmsrehabsystemsinc.com) reported today that the Company’s Board will take whatever measures required to build a strong and stable market for trading in the Company’s stock which is currently listed on the OTC Markets-pink current trading platform.
Explains Michael S. Wexler, Company Chairman and CEO, “We are seeing an anomaly in market trading activities that may well be difficult to understand, not only by the Company, but shareholders and market players as well. I want to assure all of our stakeholders and market participants that the fundamentals of our company in terms of corporate initiatives reported earlier in the year for VMS and its generic drug unit BioPharmcor B.V. ( www.biopharmcor.com) are not only intact but serve as guidance for the Company’s growth and development activities today and tomorrow. Most importantly, we are aggressively pursuing a number of funding initiatives within our drug unit to ensure that BioPharmcor meets our timeline for completing human trials on its tadalafil development program prior to the end of 2016. We anticipate that additional new generic drug programs to build out BioPharmcor’s drug pipeline will be reported within 60-90 days.”
VMS’ drug unit BioPharmcor B.V. is currently developing a generic tadalafil drug product which is recognized as a first line treatment for men suffering from Erectile Deficiency (ED) and Benign Prostatic Hyperplasia (BPH).
Established in 1998, VMS Rehab Systems Inc. is headquartered in Ottawa, Canada and maintains affiliate offices in Amsterdam, The Netherlands and Warsaw, Poland. The shares of VMS Rehab Systems Inc are listed on the US OTC Pink Current Market (Symbol: VRSYF)
Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "will" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Corporation's current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the Corporation. The forward-looking information contained in this release is made as of the date hereof and the Corporation is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.
For more information contact:
VMS Rehab Systems, Inc
In Canada: 1-613-292-2307
In Europe: +48-787-668-861